Takeda.
company in Rome, Italy
- Reports this week
- 0
- Active events
- 0
- Connections
- 27
What's happening
One to three months ago
-
Takeda is conducting Phase 3 studies in Japan.Some support2 reports
-
Takeda and Protagonist Therapeutics secured global co-development rights and received FDA approval for a drug treating rare blood cancer.Some support1 report
-
Takeda announced FDA approval of its drug MIMRYLO, a decision supported by VERIFY results.Some support3 reports
Gone quiet
No new reports in 90+ days-
India approved Takeda's dengue vaccine.Some support11 reports
-
Insilico Medicine and Takeda announced a strategic collaboration to advance drug candidates.Some support4 reports
-
Alkermes and Takeda are developing orexin-related therapies and plan to present detailed data at a meeting on July 21, 2025.Some support1 report
-
Galapagos and Takeda entered a collaboration and licensing agreement for TYK2 inhibitor development.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Takeda this week
News at the entities that move Takeda most-
FDA StructuralHHS policy allows peptides in compounding pharmacies despite FDA lack of approval, with RFK Jr. arguing for safer compounds.Moves Takeda
-
Tokyo Stock Exchange StructuralSumitomo Chemical was listed on the Tokyo Stock Exchange in January 2025.Moves Takeda
-
Novavax StructuralNovavax stock is trading on the Nasdaq electronic stock exchange, with company news and ratings being aggregated by MarketBeat.Moves Takeda
-
NIP Mentioned togetherNIP acquires Bitcoin mining machines.Moves Takeda
Connections
The 9 strongest of 27, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Julie Kim Structural
Julie Kim was appointed President and CEO of Takeda, establishing an ongoing executive leadership role.
-
Tokyo Stock Exchange Structural
Takeda is a company whose shares are listed and actively traded on the Tokyo Stock Exchange.
-
Christophe Weber Structural
Christophe Weber served as the chief executive officer of Takeda before retiring from the company and board.
-
FDA Structural
The FDA formally regulates Takeda's pharmaceutical products, granting approvals and accepting new drug applications.
-
Insilico Medicine Operational
Insilico Medicine and Takeda are engaged in a strategic partnership focused on leveraging AI platforms to co-develop drug candidates.
-
Novavax Structural
Takeda provides financial support to Novavax through royalty payments, boosting its market outlook.
-
KROS Operational
The two companies are engaged in an ongoing global development partnership where Takeda leads the clinical trial milestones and payments.
-
Verify Operational
Verify provided results supporting Takeda's MIMRYLO regulatory approval.
Show all 9 connections
-
NIP Mentioned together
Evidence suggests Takeda is seeking inclusion in a public health program, but NIP's involvement is not mentioned.